tiprankstipranks
Company Announcements

JPMorgan Chase Acquires Significant Stake in Alterity Therapeutics

Story Highlights
  • JPMorgan Chase & Co. now holds 5.13% voting power in Alterity Therapeutics.
  • This investment by JPMorgan could influence Alterity’s market position and stakeholder interests.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
JPMorgan Chase Acquires Significant Stake in Alterity Therapeutics

An announcement from Alterity Therapeutics Ltd. ( (AU:ATH) ) is now available.

JPMorgan Chase & Co. and its affiliates have become substantial holders in Alterity Therapeutics Ltd, acquiring a 5.13% voting power in the company. This acquisition signifies a notable investment by a major financial institution, potentially impacting Alterity Therapeutics’ market position and stakeholder interests.

More about Alterity Therapeutics Ltd.

Average Trading Volume: 100

Technical Sentiment Consensus Rating: Buy

Current Market Cap: $42.1M

For an in-depth examination of ATH stock, go to TipRanks’ Stock Analysis page.

Questions or Comments about the article? Write to editor@tipranks.com

Questions or Comments about the article? Write to editor@tipranks.com
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App